Earnings Feed
Start Free
Home/Filings/4/0001562180-17-003380
4//SEC Filing

Gould Kevin S 4

Accession 0001562180-17-003380

CIK 0000842023other
View on SEC.govCompany Profile

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 4:56 PM ET

Size

20.7 KB

Accession

0001562180-17-003380

Insider Transaction Report

Form 4
Period: 2017-10-26
BIO-TECHNE CorpTECH
Gould Kevin S
SVP Clinical Controls
Transactions
  • Award

    Restricted Stock Units

    2017-10-26+1,949→ 1,949 total
    → Common Stock (1,949 underlying)
  • Award

    Stock Options (Right to buy)

    2017-10-26+14,323→ 14,323 total
    Exercise: $125.05Exp: 2024-08-09→ Common Stock (14,323 underlying)
  • Award

    Stock Options (Right to buy)

    2017-10-26+10,742→ 10,742 total
    Exercise: $125.05Exp: 2024-08-09→ Common Stock (10,742 underlying)
Holdings

  • Common Stock

    1,355

  • Restricted Stock Units

    → Common Stock (2,111 underlying)
    2,111

  • Stock Options (Right to Buy)

    Exercise: $106.59Exp: 2023-08-18→ Common Stock (17,371 underlying)
    17,371

  • Stock Options (Right to Buy)

    Exercise: $88.23Exp: 2023-01-04→ Common Stock (10,000 underlying)
    10,000

  • Stock Options (Right to Buy)

    Exercise: $97.23Exp: 2022-07-09→ Common Stock (50,000 underlying)
    50,000

  • Stock Options (Right to Buy)

    Exercise: $97.23Exp: 2022-07-09→ Common Stock (15,000 underlying)
    15,000

  • Stock Options (Right to Buy)

    Exercise: $106.59Exp: 2023-08-18→ Common Stock (13,028 underlying)
    13,028
Footnotes (9)
  • [F1]Includes 834 shares of restricted stock units that vest on 7/9/18.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F3]Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F4]Vests 3,580 shares on 8/9/2018 and 3,581 shares each on 8/9/2019, 8/9/2020, 8/9/2021.
  • [F5]Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F6]Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20.
  • [F7]50,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/18.
  • [F8]Vests as to 3,750 shares on each of 7/9/16, 7/9/17, 7/9/18 and 7/9/19.
  • [F9]Vests as to 2,500 shares on each of 01/04/17, 01/04/18, 01/04/19 and 01/04/20.

Documents

2 files

Issuer

BIO-TECHNE Corp

CIK 0000842023

→
Entity typeother

Related Parties

1
  • filerCIK 0001662638

Filing Metadata

Form type
4
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 4:56 PM ET
Size
20.7 KB
View on SEC.gov